N@N

Mark Breidenbach Initiated (ALLO) at Buy and Held Target at $28 on, Jun 26th, 2023

Mark Breidenbach of Oppenheimer, Initiated "Allogene Therapeutics, Inc." (ALLO) at Buy and Held Target at $28 on, Jun 26th, 2023.

Mark has made no other calls on ALLO in the last 4 months.

There are 9 other peers that have a rating on ALLO. Out of the 9 peers that are also analyzing ALLO, 3 agree with Mark's Rating of Hold. Following are those relevant analyst calls for the last 4 months

---

• Benjamin Burnett of "Stifel" Maintained at Hold with Decreased Target to $7.5 on, Thursday, May 4th, 2023
• William Pickering of "Bernstein" Initiated at Hold and Held Target at $6 on, Tuesday, March 21st, 2023
• Benjamin Chaiken of "JMP Securities" Maintained at Hold with Decreased Target to $19 on, Thursday, March 2nd, 2023

These are the ratings of the 6 analyists that currently disagree with Mark

---

• Robert Burns of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $23 on, Tuesday, June 20th, 2023
• John Newman of "Canaccord Genuity" Reiterated at Strong Buy and Held Target at $35 on, Friday, June 16th, 2023
• Tony Butler of "EF Hutton" Reiterated at Strong Buy and Held Target at $15 on, Monday, June 5th, 2023
• Reni Benjamin of "JMP Securities" Reiterated at Buy and Held Target at $15 on, Monday, June 5th, 2023
• Luca Issi of "RBC Capital" Reiterated at Buy and Held Target at $15 on, Thursday, May 4th, 2023
• Salveen Richter of "Goldman Sachs" Maintained at Strong Buy with Decreased Target to $31 on, Thursday, March 2nd, 2023

Contributing Sources

---